NEBIVOLOL A NOVEL SOMEWHAT DIFFERENT ΒETA ADRENERGIC RECEPTOR BLOCKER
نویسندگان
چکیده
منابع مشابه
Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
Nebivolol is a novel beta1-blocker with a greater degree of selectivity for beta1-adrenergic receptors than other agents in this class and a nitric oxide (NO)-potentiating, vasodilatory effect that is unique among beta-blockers currently available to clinicians (nebivolol is approved in Europe and is currently under review in the US). A NO-potentiating agent such as nebivolol may have an import...
متن کاملNebivolol (bystolic), a novel Beta blocker for hypertension.
188 P&T® • April 2009 • Vol. 34 No. 4 INTRODUCTION Hypertension is an asymptomatic condition of persistently elevated blood pressure (BP) that affects approximately 50 million Americans and one billion people worldwide. It has been associated with other diseases and events such as myo cardial infarction (MI), heart failure, stroke, and kidney disease. Although hypertension the most common prima...
متن کاملProtective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats
BACKGROUND Renal dysfunction is very common in patients with advanced liver cirrhosis and portal hypertension. The development of renal failure in the absence of clinical, anatomical or pathological causes renal of failure is termed hepatorenal syndrome (HRS). AIM The present study was constructed to investigate the possible protective effects of nebivolol (Nebi) against D-galactosamine (Gal)...
متن کاملCorrection: Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
Correction: Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis Georgios Liappas, Guadalupe González-Mateo, Anna Rita Aguirre, Hugo Abensur, Patricia Albar-Vizcaino, Emilio González Parra, Pilar Sandoval, Laura García Ramírez, Gloria del Peso, Juan Manuel Acedo, María A. Bajo, Rafael Selgas, José A. Sánchez Tomero, Manuel López-Cabrera...
متن کاملNebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
UNLABELLED Peritoneal dialysis (PD) is a form of renal replacement treatment, which employs the peritoneal membrane (PM) to eliminate toxins that cannot be removed by the kidney. The procedure itself, however, contributes to the loss of the PM ultrafiltration capacity (UFC), leading consequently to the technique malfunction. β-blockers have been considered deleterious for PM due to their associ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Drug Delivery and Therapeutics
سال: 2013
ISSN: 2250-1177
DOI: 10.22270/jddt.v3i6.695